Marianne Greer

Marianne Greer discloses dealings in CanniMed Therapeutics Inc. to SEDI. In total, 3 filings cover trades dated from 1 November 2016 to 28 November 2017.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 29 November 2017, reports an option exercise of €7,975 in CanniMed Therapeutics Inc. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.